Nagayama D

References (2)

Title : Effects of Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on the Parameters of Glucose Metabolism and the Cardio-Ankle Vascular Index in Individuals with Type 2 Diabetes - Nagayama_2024_J.Clin.Med_13_
Author(s) : Nagayama D , Kawana H , Watanabe Y , Horikawa O , Ohira M , Saiki A
Ref : J Clin Med , 13 : , 2024
Abstract : Nagayama_2024_J.Clin.Med_13_
ESTHER : Nagayama_2024_J.Clin.Med_13_
PubMedSearch : Nagayama_2024_J.Clin.Med_13_
PubMedID: 38256615

Title : C5 variant is associated with decreased risk of coronary artery disease in outpatients with severe hypercholinesterasemia - Nagayama_2014_Int.J.Clin.Pharmacol.Ther_52_471
Author(s) : Nagayama D , Murano T , Saiki A , Shirai K , Tatsuno I
Ref : Int J Clinical Pharmacology & Therapeutics , 52 :471 , 2014
Abstract : Nagayama_2014_Int.J.Clin.Pharmacol.Ther_52_471
ESTHER : Nagayama_2014_Int.J.Clin.Pharmacol.Ther_52_471
PubMedSearch : Nagayama_2014_Int.J.Clin.Pharmacol.Ther_52_471
PubMedID: 24755128